Literature DB >> 22345594

Mechanistic view of risk factors for venous thromboembolism.

Pieter H Reitsma1, Henri H Versteeg, Saskia Middeldorp.   

Abstract

Venous thromboembolism is an episodic disease with an annual incidence of 2 to 3/1000 per year that is associated with a high morbidity and mortality. Risk factors for venous thromboembolism come in many guises. They fit into an extended version of Virchow's triad and they tilt the hemostatic balance toward clot formation. This can be achieved by decreasing blood flow and lowering oxygen tension, by activating the endothelium, by activating innate or acquired immune responses, by activating blood platelets, or by increasing the number of platelets and red blood cells or modifying the concentrations of pro- and anticoagulant proteins in the blood. In this narrative review we will discuss the known common risk factors within this pathophysiological framework.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345594     DOI: 10.1161/ATVBAHA.111.242818

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  53 in total

1.  Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis.

Authors:  Frank C Vandy; Cathy Stabler; Anna M Eliassen; Angela E Hawley; Kenneth E Guire; Daniel D Myers; Peter K Henke; Thomas W Wakefield
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2013-04-01

Review 2.  New insights into modulation of thrombin formation.

Authors:  Henri M H Spronk; Julian I Borissoff; Hugo ten Cate
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 3.  Recent pharmacological advances for treating venous thromboembolism: are we witnessing the demise of warfarin?

Authors:  Shankar Kumar; John Howell; Christopher Mattock
Journal:  J R Soc Med       Date:  2013-09-11       Impact factor: 5.344

Review 4.  Association between B-group vitamins and venous thrombosis: systematic review and meta-analysis of epidemiological studies.

Authors:  Kuangguo Zhou; Ruizhi Zhao; Zhe Geng; Lijun Jiang; Yang Cao; Danmei Xu; Yin Liu; Liang Huang; Jianfeng Zhou
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

5.  Identification of Common and Rare Genetic Variation Associated With Plasma Protein Levels Using Whole-Exome Sequencing and Mass Spectrometry.

Authors:  Terry Solomon; John D Lapek; Søren Beck Jensen; William W Greenwald; Kristian Hindberg; Hiroko Matsui; Nadezhda Latysheva; Sigrid K Braekken; David J Gonzalez; Kelly A Frazer; Erin N Smith; John-Bjarne Hansen
Journal:  Circ Genom Precis Med       Date:  2018-12

6.  Autoimmune diseases and venous thromboembolism: a review of the literature.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

7.  Pregnancy causes diminished myogenic tone and outward hypotrophic remodeling of the cerebral vein of Galen.

Authors:  Anne-Eva van der Wijk; Malou P H Schreurs; Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-02       Impact factor: 6.200

8.  Pulmonary Embolism Following Outpatient Vasectomy.

Authors:  Frank E Mott; Bilal Farooqi; Harry Moore
Journal:  Curr Urol       Date:  2016-02-10

9.  Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report.

Authors:  Dong Wang; Min Tian; Guanglin Cui; Dao Wen Wang
Journal:  Front Med       Date:  2017-08-31       Impact factor: 4.592

10.  Direct oral anticoagulant treatment of deep vein thrombosis reduces IL-6 expression in peripheral mono-nuclear blood cells.

Authors:  Saverio Candido; Giovanni Lumera; Giuliana Barcellona; Davide Vetri; Elda Tumino; Ingrid Platania; Evelise Frazzetto; Graziella Privitera; Carmela Incognito; Agostino Gaudio; Salvatore Santo Signorelli
Journal:  Exp Ther Med       Date:  2020-10-21       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.